Where can I find news about BIOE?

The latest headlines, third-party analysis, and SEC filings for Bio Essence Corporation (BIOE) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.

Where are BIOE's SEC filings?

Bio Essence Corporation (BIOE)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.

Where are BIOE's earnings call transcripts?

Full earnings call transcripts for Bio Essence Corporation (BIOE) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

BIOE

Bio Essence Corporation

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.25$0.00+0.00%

After hours·$0.25+0.00%

Market cap$9.90M·Market closed·Aug 26 8:00 PM UTC

News & Analysis

Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio
Global AI in Fitness and Wellness Market Size was valued at USD 10.68 Billion in 2025 and is predicted to reach USD 57.80 Billion by the year 2035 at a 19.3% CAGR during the forecast period for 2026 to 2035. IRVINE, CA / ACCESS Newswire / April 27, 2026 / Bio Essence Corporation (OTCQB:BIOE) ("Bio Essence" or the "Company"), a specialized health and wellness provider, today announced that it has entered into a definitive Asset Purchase Agreement to acquire the MediFlow AI platform from Zhituo Software Co., Limited.
accessnewswire.comApr 27, 2026 · 8:00 AM
BIO ESSENCE CORP (OTCQB:BIOE) Announces Approval for Upgrade to the OTCQB Market, Effective February 26, 2026
The company's approval to upgrade to the OTCQB Venture Market underscores a growing trend among international, growth-stage companies to expand U.S. investor access and enhance market liquidity. The OTCQB® Venture Market is designed for entrepreneurial and development-stage companies in the United States and abroad.
accessnewswire.comMar 3, 2026 · 8:00 AM

SEC Filings

10-Q
Aug 14, 2026View on SEC
8-K/A
May 19, 2026View on SEC
10-Q
May 15, 2026View on SEC
8-K
Apr 23, 2026View on SEC
10-K
Mar 27, 2026View on SEC
QUALIF
Jan 6, 2026View on SEC

Frequently Asked Questions About BIOE

Where can I find news about BIOE?: The latest headlines, third-party analysis, and SEC filings for Bio Essence Corporation (BIOE) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are BIOE's SEC filings?: Bio Essence Corporation (BIOE)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are BIOE's earnings call transcripts?: Full earnings call transcripts for Bio Essence Corporation (BIOE) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.

Bio Essence Corporation

Frequently Asked Questions About BIOE

Bio Essence Corporation

Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio

BIO ESSENCE CORP (OTCQB:BIOE) Announces Approval for Upgrade to the OTCQB Market, Effective February 26, 2026

Frequently Asked Questions About BIOE

Bio Essence Corporation (OTCQB: BIOE) to Acquire MediFlow AI Platform, Strengthening Its Human Health and Wellness Portfolio

BIO ESSENCE CORP (OTCQB:BIOE) Announces Approval for Upgrade to the OTCQB Market, Effective February 26, 2026